CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
40,59
10-января-25 16:00:05
15 мин. задержка
Акции
-7,91
-16,31%
Сегодняшний диапазон
40,04 - 47,56
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 май 2023 16:21:55 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
04 май 2023 16:05:12 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 апр 2023 16:31:01 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 мар 2023 16:37:50 Источник Nasdaq GlobeNewswire
-
28 фев 2023 16:05:39 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 фев 2023 17:21:42 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
10 фев 2023 08:01:33 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 янв 2023 16:48:48 Источник Nasdaq GlobeNewswire
-
09 янв 2023 08:01:39 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Provides Update on CRN04777 Program
28 ноя 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
22 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 ноя 2022 16:30:43 Источник Nasdaq GlobeNewswire
-
13 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 окт 2022 16:57:25 Источник Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
08 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire